Werewolf Therapeutics, Inc. (HOWL)

Werewolf Therapeutics Revenue

Werewolf Therapeutics had revenue of $1.14M in the twelve months ending March 31, 2025, down -92.95% year-over-year. In the year 2024, Werewolf Therapeutics had annual revenue of $1.89M, down -90.55%.

• Revenue (ttm): $1.14M
• Revenue Growth: -92.95%
• P/S Ratio: 49.81
• Revenue / Employee: $24,848
• Employees: 46
• Market Cap: 58.78M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.89M	-18.06M	-90.55%
Dec 31, 2023	19.94M	3.54M	21.60%
Dec 31, 2022	16.40M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.